Ascension | Sacred Heart Pensacola Oncology logo

Ascension | Sacred Heart Pensacola Oncology

Research site
About
Yazan Alsayed, M.D.; Alexander Brown, M.D.; Ranjith Dissanayake, M.D.; Dany El-Sayah, M.D.; Mose Hayes, M.D.; James Watkins, M.D.; Zachary Wright, M.D., F.A.C.P.
Location
1545 Airport Boulevard Ste 3000, Pensacola, Florida, United States of America
Site insights

Top conditions

Breast Cancer (7 trials)

Lung Cancer (6 trials)

Lymphoma (4 trials)

Carcinoma (3 trials)

Plasma Cell Cancer (3 trials)

Top treatments

Pembrolizumab
Lenalidomide
Bevacizumab
Sacituzumab
Carboplatin
Nivolumab
Paclitaxel
Olaparib
Zanubrutinib
Venetoclax

Parent organization

This site is a part of Ascension

Data sourced from clinicaltrials.gov

Trials

6 of 32
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma (MAHOGANY)

The purpose of the study is to compare the efficacy of zanubrutinib plus obinutuzumab versus lenalidomide plus rituximab (R^2) in participants with r...

Enrolling
Relapsed/Refractory Follicular Lymphoma
Marginal Zone Lymphoma
Drug: Rituximab
Drug: Zanubrutinib

Follicular lymphoma (FL), marginal zone lymphoma (MZL), and mantle cell lymphoma (MCL) are distinct histologic types of B-cell NHL. Lenalidomide is a...

Active, not recruiting
Lymphoma, Non-Hodgkin
Drug: Rituximab
Drug: Lenalidomide

This phase III trial compares the effect of the combination of ramucirumab and pembrolizumab versus standard of care chemotherapy for the treatment o...

Enrolling
Recurrent Lung Non-Small Cell Carcinoma
Stage IV Lung Cancer AJCC v8
Biological: Pembrolizumab
Biological: Ramucirumab

This is a phase 3 study to compare the efficacy and safety of HBI-8000 or Placebo combined with nivolumab on patients with unresectable or metastatic...

Enrolling
Progressive Brain Metastasis
Unresectable or Metastatic Melanoma
Drug: Placebo in combination with nivolumab
Drug: HBI-8000 in combination with nivolumab

The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surg...

Enrolling
Triple Negative Breast Cancer
Drug: Capecitabine
Drug: Sacituzumab govitecan-hziy (SG)

The primary objective of this study is to compare the progression-free survival (PFS) between sacituzumab govitecan-hziy (SG) versus treatment of phy...

Enrolling
Triple Negative Breast Cancer
PD-L1 Negative
Drug: Paclitaxel
Drug: Gemcitabine

Trial sponsors

S

SWOG Cancer Research Network (7 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems